Savvy Updates 4/14/25: DRI “Aggressively Working” on T1D Cure, Microbiome Therapy To Delay T1D Onset, Fully Closed AID Systems Effective, 025 Breakthroughs in D Research, D Distress Linked to Autonomic Symptoms, Medtech Industry Presses for Tariff Exemptions, Hearing & Heart Failure Risk, New Type of D 5, Heat & Kidney Transplant Recipients, Ex-FDA Chief Cites ‘Dysfunctional’ Congress, FTC Chair on PBM Insulin Case, Nursing Home Staffing Mandate Struck Down, Alcohol Changes Fat Levels

Savvy Updates 4/14/25: DRI “Aggressively Working” on T1D Cure, Microbiome Therapy To Delay T1D Onset, Fully Closed AID Systems Effective, 025 Breakthroughs in D Research, D Distress Linked to Autonomic Symptoms, Medtech Industry Presses for Tariff Exemptions, Hearing & Heart Failure Risk, New Type of D 5, Heat & Kidney Transplant Recipients, Ex-FDA Chief Cites ‘Dysfunctional’ Congress, FTC Chair on PBM Insulin Case, Nursing Home Staffing Mandate Struck Down, Alcohol Changes Fat Levels

Apr 14, 2025 | Advocacy, Diabetes Business, Featured, Podcasts, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Diabetes Research Institute (DRI) “Aggressively Working” on T1D Cure Microbiome Therapy To Delay T1D Onset Fully Closed AID Systems Effective Without Meal Announcements 2025 Breakthroughs in Diabetes...
Savvy Updates 4/7/25: Diabetes Treatment Breakthroughs, Saccharin Kills Multidrug-Resistant Bacteria, D & Bone Health, Avoiding Hypos During Exercise, GlucoSense App

Savvy Updates 4/7/25: Diabetes Treatment Breakthroughs, Saccharin Kills Multidrug-Resistant Bacteria, D & Bone Health, Avoiding Hypos During Exercise, GlucoSense App

Apr 7, 2025 | Diabetes Business, Featured, Podcasts, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Diabetes Treatment Breakthroughs: Harmine to Stimulate Beta Cell Replication; Sana BioTechnology Islet Transplantation without Immunosuppression, AI-powered insulin delivery system Saccharin Kills...
Savvy Updates, 12/16/24: ADA DiabetesStandards of Care 2025, Cleerly CCTA, Eversense 365 Day CGM Video, Insulin Resistance & Aortic Stenosis, Medtronic CGM Data on Displays, Effort to Force Insurers, PBMs to Sell Pharmacy Businesses, Medicare Open Enrollment Stress

Savvy Updates, 12/16/24: ADA DiabetesStandards of Care 2025, Cleerly CCTA, Eversense 365 Day CGM Video, Insulin Resistance & Aortic Stenosis, Medtronic CGM Data on Displays, Effort to Force Insurers, PBMs to Sell Pharmacy Businesses, Medicare Open Enrollment Stress

Dec 16, 2024 | Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  ADA DiabetesStandards of Care 2025 Cleerly Coronary Computed Tomography Angiography (CCTA) Video: Implantable 365-Day CGM Procedure Biomarkers of Insulin Resistance & Aortic Stenosis Medtronic CGM Data on...
Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Jul 15, 2024 | Advocacy, Diabetes Business, Featured, Podcasts, Research News, Technology Updates, Videos

Novo’s once-weekly insulin rejected by FDA by Kristin Jensen for BioPharmaDive.com, 11 July 2024. Novo is one of the world’s premier manufacturers, along with Indianapolis-based Eli Lilly. Both have been working for years to offer patients a more convenient option...
Skip to content